Codoxo Secures $35 Million Series C as Point Zero Model Scales Across U.S. Payers

New updates have been reported about Codoxo.

Codoxo has capped a breakout year with an oversubscribed $35 million Series C round led by CVS Health Ventures, funding national expansion of its Point Zero Payment Integrity model that intervenes before healthcare claims are created. The company reported strong year-over-year revenue growth, 100% customer retention, and 125% net revenue retention, with its GenAI-powered Unified Cost Containment Platform now supporting payment integrity operations for more than 80 million covered lives.

By shifting intervention to the pre-claim stage through proactive, AI-driven provider education, Codoxo says payers are realizing $12–$16 per member per year in savings at Point Zero and up to $66 per member per year across the broader payment spectrum, while cutting overpayments by as much as 40%. New capabilities launched over the past year include the Data Health Integrity Agent for higher-fidelity data sharing, a Policy-to-Code engine that converts complex policy language into executable rules, and Deepfake Detection to identify synthetic medical documents, all delivered under NIST 800-53 Rev. 5 and HITRUST r2 controls as the company advances toward FedRAMP readiness.